《CELL,6月9日,Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9》

  • 来源专题:COVID-19科研动态监测
  • 编译者: xuwenwhlib
  • 发布时间:2020-06-14
  • Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9

    Dene R. Littler

    Benjamin S. Gully

    Rhys N. Colson

    Jamie Rossjohn #

    Show footnotes

    Open AccessPublished:June 09, 2020DOI:https://doi.org/10.1016/j.isci.2020.101258

    Summary

    Many of the SARS-CoV-2 proteins have related counterparts across the Severe Acute Respiratory Syndrome (SARS-CoV) family. One such protein is non-structural protein 9 (Nsp9), which is thought to mediate viral replication, overall virulence and viral genomic RNA reproduction. We sought to better characterise the SARS-CoV-2 Nsp9 and subsequently solved its X-ray crystal structure, in an apo-form and, unexpectedly, in a peptide-bound form with a sequence originating from a rhinoviral 3C protease sequence (LEVL). The SARS-CoV-2 Nsp9 structure revealed the high level of structural conservation within the Nsp9 family. The exogenous peptide binding site is close to the dimer interface and impacted the relative juxtapositioning of the monomers within the homodimer. We have established a protocol for the production of SARS-CoV-2 Nsp9, determined its structure and identified a peptide-binding site that warrants further study to understanding Nsp9 function.

  • 原文来源:https://www.cell.com/iscience/fulltext/S2589-0042(20)30444-2
相关报告
  • 《6月9日_澳大利亚莫纳什大学等解析SARS-CoV-2非结构蛋白9(Nsp9)的晶体结构》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-06-13
    • 1.时间:2020年6月9日 2.机构或团队:澳大利亚莫纳什大学、英国卡迪夫大学 3.事件概要 澳大利亚莫纳什大学和英国卡迪夫大学的科研人员在期刊iScience在线发表题为“Crystal structure of the SARS-CoV-2 non-structural protein 9, Nsp9”的文章。 文章指出,许多SARS-CoV-2蛋白在严重急性呼吸综合征(SARS-CoV)家族中都有类似蛋白,其中一种蛋白质是非结构蛋白9 (Nsp9),被认为与病毒的复制、整体毒性以及病毒基因组RNA复制有关。研究人员为了更好地表述了SARS-CoV-2 Nsp9的特征,以脱辅基形式和以肽结合形式确定了其X射线晶体结构,该序列起源于鼻病毒的3C蛋白酶序列(LEVL)。SARS-CoV-2 Nsp9结构显示了Nsp9家族中高度的结构保护性。外源肽结合位点靠近二聚体界面,影响同型二聚体中单体的相对并置。研究人员已经建立了一种生成SARS-CoV-2 Nsp9的方案,确定了其结构,并确定了一个肽结合位点,这需要进一步研究来了解Nsp9的功能。 4.附件: 原文链接:https://www.cell.com/iscience/fulltext/S2589-0042(20)30444-2
  • 《bioRxiv,6月9日,Structural basis of a public antibody response to SARS-CoV-2》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-06-10
    • Structural basis of a public antibody response to SARS-CoV-2 View ORCID ProfileMeng Yuan, Hejun Liu,  View ORCID ProfileNicholas C. Wu,  View ORCID ProfileChang-Chun D. Lee,  View ORCID ProfileXueyong Zhu,  View ORCID ProfileFangzhu Zhao,  View ORCID ProfileDeli Huang, Wenli Yu, Yuanzi Hua, Henry Tien, Thomas F. Rogers, Elise Landais, Devin Sok, Joseph G. Jardine, Dennis R. Burton, Ian A. Wilson doi: https://doi.org/10.1101/2020.06.08.141267 Abstract Molecular-level understanding of human neutralizing antibody responses to SARS-CoV-2 could accelerate vaccine design and facilitate drug discovery. We analyzed 294 SARS-CoV-2 antibodies and found that IGHV3-53 is the most frequently used IGHV gene for targeting the receptor binding domain (RBD) of the spike (S) protein. We determined crystal structures of two IGHV3-53 neutralizing antibodies +/- Fab CR3022 ranging from 2.33- to 3.11-angstrom resolution. The germline-encoded residues of IGHV3-53 dominate binding to the ACE2 binding site epitope with no overlap with the CR3022 epitope. Moreover, IGHV3-53 is used in combination with a very short CDR H3 and different light chains. Overall, IGHV3-53 represents a versatile public VH in neutralizing SARS-CoV-2 antibodies, where their specific germline features and minimal affinity maturation provide important insights for vaccine design and assessing outcomes.